Skip to main content

Research Repository

Advanced Search

?v?6 integrin may be a potential prognostic biomarker in interstitial lung disease

Saini, Gauri; Porte, Joanne; Weinreb, Paul H; Violette, Sheila M; Wallace, William A; McKeever, Tricia M.; Jenkins, Gisli

?v?6 integrin may be a potential prognostic biomarker in interstitial lung disease Thumbnail


Gauri Saini

Joanne Porte

Paul H Weinreb

Sheila M Violette

William A Wallace

Professor of Epidemiology and Medical Statistics

Gisli Jenkins


Idiopathic pulmonary fibrosis (IPF) and fibrotic nonspecific interstitial pneumonitis are progressive interstitial lung diseases (ILDs) with limited treatment options and poor survival. However, the rate of disease progression is variable, implying there may be different endotypes of disease. We hypothesised that immunophenotyping biopsies from ILD patients might reveal distinct endotypes of progressive fibrotic disease, which may facilitate stratification when undertaking clinical trials of novel therapies for IPF.43 paraffin-embedded, formalin-fixed lung tissue sections were immunostained for five molecules implicated in the pathogenesis of the fibrosis: ?-smooth muscle actin (?SMA), ?v?6 integrin, pro-surfactant protein C (SP-C), hepatocyte growth factor (HGF) and tenascin-C (TenC). Levels of immunostaining and numbers of fibroblastic foci were quantified using operator-dependent and -independent methods. The relationship of all these markers to overall survival was analysed.Staining revealed high levels of ?SMA, ?v?6 integrin, pro-SP-C, HGF and TenC, and fibroblastic foci. Immunostaining varied across samples for all molecules but only the extent of ?v?6 integrin immunostaining was associated with increased mortality. There was no association with the other markers measured.Our data suggest high levels of ?v?6 integrin may identify a specific endotype of progressive fibrotic lung disease.


Saini, G., Porte, J., Weinreb, P. H., Violette, S. M., Wallace, W. A., McKeever, T. M., & Jenkins, G. (2015). ?v?6 integrin may be a potential prognostic biomarker in interstitial lung disease. European Respiratory Journal, 46(2), 486-494.

Journal Article Type Article
Acceptance Date Jan 16, 2015
Online Publication Date Mar 5, 2015
Publication Date 2015-08
Deposit Date May 8, 2017
Publicly Available Date May 8, 2017
Journal European Respiratory Journal
Print ISSN 0903-1936
Electronic ISSN 1399-3003
Publisher European Respiratory Society
Peer Reviewed Peer Reviewed
Volume 46
Issue 2
Pages 486-494
Public URL
Publisher URL


You might also like

Downloadable Citations